Physician profile
James Patrick Mackrell
NPI 1295713949
$431.28
in general payments reported to CMS, 2019-2025
8 companies · $88.08 in 2025
The $88.08 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2021: $86.12 · 2022: $39.22 · 2023: $19.82 · 2024: $19.19 · 2025: $88.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $115.00 | 2021-2025 | Watchman Flx |
| Pfizer INC. | $98.84 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $62.25 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $56.88 | 2019 | |
| Abbott Laboratories | $43.12 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Philips North America LLC | $22.79 | 2019 | |
| Scpharmaceuticals INC. | $19.19 | 2024 | |
| Cvrx, INC. | $13.21 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mackrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.